Your browser doesn't support javascript.
loading
Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma.
Li, Lei; Xun, Chen; Yu, Chun-Hong.
Afiliação
  • Li L; Department of Pathology, University of Otago, Dunedin 9016, New Zealand.
  • Xun C; Department of Hepatobiliary Surgery, Zhuzhou Central Hospital, Zhuzhou 412000, Hunan Province, China.
  • Yu CH; School of Engineering Medicine, Beihang University, Beijing 100191, China. chunhongyu@buaa.edu.cn.
World J Hepatol ; 14(12): 1985-1996, 2022 Dec 27.
Article em En | MEDLINE | ID: mdl-36618329
ABSTRACT
Among the most common cancers, hepatocellular carcinoma (HCC) has a high rate of tumor recurrence, tumor dormancy, and drug resistance after initial successful chemotherapy or radiotherapy. A small subset of cancer cells, cancer stem cells (CSCs), exhibit stem cell characteristics and are present in various cancers, including HCC. The dysregulation of microRNAs (miRNAs) often accompanies the occurrence and development of HCC. miRNAs can influence tumorigenesis, progression, recurrence, and drug resistance by regulating CSCs properties, which supports their clinical utility in managing and treating HCC. This review summarizes the regulatory effects of miRNAs on CSCs in HCC with a special focus on their impact on HCC recurrence.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Hepatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Hepatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nova Zelândia